As the only conference to bring together all the experts in the biopharmaceutical industry, attracting over 175 senior level decision makers from Europe and the US, this exciting and important meeting is a must for anyone working in the field of follow on biologics
The Congress features two streams:
Market Opportunities & Commercial Challenges: In Stream 1, the meeting will address the most pressing challenges in gaining access to emerging markets and branding biosimilars. Boisimilars experts will also debate how to overcome regulatory challenges, outsource manufacturing and develop pricing strategies
Developing Biosimilars & Biobetters: Learn more about current developments in clinical trials, including pharmacovigilence and patient safety. Do not miss out on the chance to discover innovative solutions for achieving quality by design, demonstrating biosimilarity and addressing potency, as well as the latest insights into regulatory requirements.